HealthAustralian regulator warns after counterfeit peptide product tears patient’s oesophagus

Australia’s Therapeutic Goods Administration warned about unapproved peptide products after a patient suffered uncontrollable vomiting and tore their oesophagus while believing they were taking experimental weight-loss drug retatrutide. Testing found the counterfeit product contained semaglutide, at about eight times the amount in approved products, and no retatrutide.

Australiacounterfeit drugsweight-loss drugsmedicine safety

TThe Guardian★★★☆☆2026-09-14 02:41Original